Ubiquitous Need in Healthcare for Diagnostics & Drug Administration Coupled With Development of Smart Injection & Infusion Solutions to Drive Global Demand for Syringes
Ubiquitous need for
syringes in healthcare and the ensuing emphasis placed on innovations that
optimize safety, efficiency and effectiveness are poised to drive the global market for Syringes
to exceed US$23 billion by 2024.
Syringes
are medical devices used to inject or extract medication/liquids into or from
the body tissues. Rising
incidences of chronic diseases continue to necessitate the need for injectable
devices, hence generating the demand for syringes. In addition, demographic
factors such as an aging population requiring intensive healthcare continue to drive
the demand for syringes. Globally, growing concerns over needlestick injuries
specifically in care facilities and rising demand from consumers for
conventional syringe alternatives drive the demand for safety syringes. Prefilled
Syringes are becoming increasingly popular as they are easy-to-use and reduce the
risk of cross-contamination. Demand for prefilled syringes is
also driven by the rise in production of biologics and biopharmaceuticals. Also
contributing to the growth is the rise in drug self-administration among the
patient population, and growing preference for home based care amid efforts to
control healthcare costs, especially for chronic diseases such as diabetes.
The drive towards better and effective treatment
continues to drive advancements in technology and materials in the syringe
categories. Design and recommendations for safety syringes have evolved over
the years beginning with AD syringes for immunization programs and advancing to
syringes with re-use prevention design and sharp
injury protection features. In
view of the escalating demand for prefilled syringes, manufacturers are
concentrating efforts on adopting advanced technologies, such as with regard to
material used and lubrication technology employed to lower extractables and
leachables. Several manufacturers are now focused on developing materials that
offer better compatibility of prefilled syringes with biologic drugs and also
meet the regulatory requirements for visible and subvisible particles, and
needle safety. Human factors studies are also playing an important role in
influencing the design and manufacture of prefilled syringes to ensure ease of
use. Some of the new syringe introductions are primarily focused on ensuring
safety, intuitiveness, ergonomics, and ease of use for patients. There is a
growing focus on materials that exhibit minimal interaction with sensitive and
complex drugs such as biologics and biosimilars
As
stated by the new market research report on Syringes,
the United States
represents the largest market worldwide. Asia-Pacific is forecast to witness
the fastest growth with a CAGR of 9.0% over the analysis period given the rapidly evolving healthcare sector in
various countries across the region, implementation of stringent infection
control standards, and growing emphasis on offering high quality medical
services to patients.
Major players in the market include Abbott
Laboratories Inc., B. Braun Melsungen AG, Becton, Dickinson and Company,
Cardinal Health, Kawamoto Corporation, Medline Industries Inc., Merit Medical
Systems, Nipro Medical Corporation, Retractable Technologies, Smiths Medical,
and Terumo Corporation among others.
The
research report titled "Syringes – Market Analysis,
Trends, and Forecasts" announced by Global Industry Analysts,
Inc.,
provides a comprehensive review of market trends, drivers, mergers,
acquisitions and other strategic industry activities. The report provides
market estimates and projections for geographic markets such as the US, Canada,
Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe),
Asia-Pacific (China, India, and Rest of Asia-Pacific), Middle East and Latin
America (Brazil and Rest of Latin America). Product segments analyzed include Sterilizable
Syringes, Disposable Syringes (Conventional Syringes and Safety Syringes), and
Prefilled Syringes Markets.
For
enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.
For cutting edge analyst reviews on top industries
Follow
us on Twitter; Connect with us on
LinkedIn;
Follow us on Medium
Comments
Post a Comment